Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals)
FDA Inspection
•Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals)•December 13, 2024

FDA Inspection 1257802 - Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals) - December 13, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals), with an inspection on December 13, 2024, issued by the Philadelphia District Office, covering human drugs.

Company
Johnson and Johnson Innovative Medicine (previously Janssen Pharmaceuticals)
Inspection Date
December 13, 2024
Product Type
Human Drugs
Office
Philadelphia District Office
Open in Dashboard

ID · 73580ef6-dd7b-4b45-a406-291936eb7957

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.